Early research (Phase 1)Study completedNCT04535167
What this trial is testing
First-In-Human Study To Evaluate Safety, Tolerability, And Pharmacokinetics Following Single Ascending And Multiple Ascending Doses of PF-07304814 In Hospitalized Participants With COVID-19.
Who this might be right for
Viral Disease
Pfizer 26